GlassScriptPhysician profile
David Jopke
NPI 1881372472
$8,539.02
in general payments reported to CMS, 2019-2025
28 companies · $5,599 in 2025
The $5,599 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $153 · 2024: $2,787 · 2025: $5,599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,105 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,200 · Travel and Lodging: $1,234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,104.79 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,200.00 |
| Travel and Lodging | $1,234.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $3,576.85 | 2024-2025 | Omnipod, Omnipod |
| Medtronic, INC. | $1,824.73 | 2024-2025 | Minimed 780g |
| Novo Nordisk INC | $503.16 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $499.35 | 2024-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Bayer Healthcare Pharmaceuticals INC. | $372.76 | 2023-2025 | |
| Abbott Laboratories | $177.73 | 2025 | Freestyle Libre 3 |
| Corcept Therapeutics | $168.28 | 2023-2025 | Korlym |
| Mannkind Corporation | $156.45 | 2024-2025 | |
| Amgen INC. | $143.34 | 2023-2025 | Evenity, Prolia, Tepezza |
| Lilly USA, LLC | $143.22 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Kyowa Kirin, INC. | $114.49 | 2024-2025 | Crysvita |
| Tandem Diabetes Care, INC. | $108.64 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Sanofi-Aventis U.S. LLC | $101.32 | 2024 | |
| Xeris Pharmaceuticals, INC. | $98.41 | 2024-2025 | Recorlev, Gvoke Hypopen |
| Radius Health, INC. | $97.75 | 2024-2025 | Tymlos |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sequel Med Tech, LLC | $79.00 | 2025 | Twiist |
| Amphastar Pharmaceuticals, INC. | $65.24 | 2024-2025 | |
| Almatica Pharma LLC | $62.69 | 2025 | Teriparatide |
| Ascensia Diabetes Care US INC. | $39.58 | 2023-2024 | |
| Recordati_rare_diseases_inc. | $38.86 | 2024-2025 | Isturisa, Signifor Lar |
| Amneal Pharmaceuticals LLC | $34.15 | 2024 | Unithroid |
| Chiesi USA, INC. | $26.86 | 2025 | Mycapssa |
| Ascendis Pharma Endocrinology INC | $24.91 | 2025 | Yorvipath |
| Soleno Therapeutics, INC. | $23.08 | 2025 | Vykat Xr |
| Globus Medical, INC. | $21.00 | 2025 | Senza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.36 | 2025 | Jardiance |
| Tolmar, INC. | $13.34 | 2024 | |
| Cequr Corporation | $6.47 | 2025 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Jopke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.